Primary gastric mantle cell lymphoma is a rare form of gastointestinal tumour. Although peritoneal carcinomatosis accompanied by malignant ascites is relatively common, mantle cell lymphoma presenting with ascites is rare. Also, effusions involving pericardial and pleural cavities are uncommon during the course of lymphomas. We report the first case in which pericardial, pleural and peritoneal effusion of a primary gastric mantle cell lymphoma.
ChanJK. Gastrointestinal lymphomas: an overview with emphasis on new findings and diagnostic problems. Semin Diagn Pathol1996; 13: 260–296.
2.
RomagueraJEMedeirosLJHagemeisterFB. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer2003; 97: 586–591. erratum in: Cancer 2003; 97: 3131.
3.
FerrerASalaverriaIBoschF. Leukemic involvement is a common feature in mantle cell lymphoma. Cancer2007; 109: 2473–2480.
4.
ChongYShinnJJChoMY. Synchronous primary gastric mantle cell lymphoma and early gastric carcinoma: a case report. Pathol Res Pract2008; 204: 407–411.
5.
YonalICiftcibasiAGokturkS. Massive ascites as the initial manifestation of mantle cell lymphoma: a challenge for the gastroenterologist. Case Rep Gastroenterol2012; 6: 803–809.
6.
DasDK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol2006; 34: 335–347.
7.
RadererMPüspökABirknerT. Primary gastric mantle cell lymphoma in a patient with long standing history of Chron’s disease. Leuk Lymphoma2004; 45: 1459–1462.
8.
WitzigTE. Current treatment approaches for mantle-cell lymphoma. J Clin Oncol2005; 23: 6409–6414.
9.
HosterEDreylingMKlapperW. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood2008; 111: 558–565.
ZapataMBudnickSDBordoniR. An uncommon case of de novo CD10+ CD5− mantle cell lymphoma mimics follicle center B cell lymphoma. Int J Clin Exp Pathol2010; 3: 430–436.
12.
SmithMDSingeltonTPBalaramanS. Case report: mantle cell lymphoma, prolymphocytoid variant, with leukostasis syndrome. Mod Pathol2004; 17: 879–883.
13.
CzaderMAliSZ. Flow cytometry as an adjunct to cytomorphologic analysis of serous effusions. Diagn Cytopathol2003; 29: 74–78.
14.
LenzGDreylingMHiddemannW. Mantle cell lymphoma: established therapeutic options and future directions. Ann Hematol2004; 83: 71–72.
15.
ViscoCFinottoSZambelloR. Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation. J Clin Oncol2013; 31: 1442–1449.
16.
ArranzRGarcía-NoblejasAGrandeC. First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELT. Haematologica2013; 98: 1563–1570.
